These important observations confirm the previous reports that acenocoumarol administration in an ischemic and edematous model of AP and the administration of warfarin in ischemia-reperfusion-induced pancreatitis significantly decrease the serum IL-1 level and led us to conclude that coumarin derivatives provide universal protection before AP [55,56,60]. Here, IL1B is linked to pancreatitis.